Home > Research > Browse

Results for incretins

Publications & Outputs

  1. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease

    Yuan, Z., Li, D., Feng, P., Xue, G., Ji, C., Li, G. & Hölscher, C., 5/10/2017, In : European Journal of Pharmacology. 812, p. 82-90 9 p.

    Research output: Contribution to journalJournal article

  2. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat

    Han, L., Holscher, C., Xue, G., Li, G. & Li, D., 6/01/2016, In : NeuroReport. 27, 1, p. 23-32 10 p.

    Research output: Contribution to journalJournal article

  3. Neuroprotective and anti-apoptotic effects of Liraglutide on SH-SY5Y cells exposed to Methylglyoxal stress

    Sharma, M., Jalewa, J. & Hölscher, C., 02/2014, In : Journal of Neurochemistry. 128, 3, p. 459-471 13 p.

    Research output: Contribution to journalJournal article

  4. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer’s disease mouse model

    Faivre, E. & Holscher, C., 8/04/2013, In : Journal of Alzheimer's Disease. 35, 2, p. 267-283 17 p.

    Research output: Contribution to journalJournal article